WallStreetZenWallStreetZen

NYSE: ATR
Aptargroup Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Aptargroup earnings were $391.5M for the trailing 12 months ending Jun 30, 2025, with 21.9% growth year over year. The latest ATR earnings report on Jun 30, 2025 announced Q2 2025 earnings of $111.7M, up 41.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ATR reported annual earnings of $374.5M, with 31.7% growth. The next ATR earnings date is Oct 30, 2025.

ATR past earnings growth

How has ATR's earnings growth performed historically?

Company
21.86%
Industry
15.3%
Market
34.06%
ATR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ATR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ATR's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ATR earnings history

Current Revenue
$3.6B
Current Earnings
$391.5M
Current Profit Margin
10.8%
ATR's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ATR Return on Equity

Current Company
15.3%
Current Industry
9.8%
Current Market
30.7%
ATR's Return on Equity (15.3%)... subscribe to Premium to read more.
High Return on Equity Performance

ATR undefined

Current Company
8.5%
Current Industry
8.1%
ATR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ATR announces earnings.

ATR undefined

Current Company
15.42%
Current Industry
10.5%
ATR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATR vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ATR$809.13M$391.50M+13.34%$5.91
STVN$346.92M$158.30M-0.81%$0.58
RGEN$86.61M-$22.98MN/A-$0.42
BAX$941.00M-$155.00MN/A-$0.30
TFX$601.38M$191.93M-16.03%$4.33
View Top Medical Stocks

ATR earnings dates

Next earnings date
Oct 30, 2025

Aptargroup Earnings Reports & History FAQ

What were Aptargroup's earnings last quarter?

On ATR's earnings call on Invalid Date, Aptargroup (NYSE: ATR) reported Q2 2025 earnings per share (EPS) of $1.69, up 24.26% year over year. Total ATR earnings for the quarter were $111.72 million. In the same quarter last year, Aptargroup's earnings per share (EPS) was $1.36.

If you're new to stock investing, here's how to buy Aptargroup stock.

When does Aptargroup report earnings?

The next ATR earnings date is Invalid Date. Add ATR to your watchlist to be reminded of Aptargroup's next earnings date.

Is Aptargroup profitable or losing money?

As of the last Aptargroup earnings report, Aptargroup is currently profitable. Aptargroup's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $391.50 million, a 22.26% increase year over year.

What was ATR's earnings growth in the past year?

As of Aptargroup's earnings date in Invalid Date, Aptargroup's earnings has grown 21.86% year over year. This is 6.56 percentage points higher than the US Medical Instruments & Supplies industry earnings growth rate of 15.3%. ATR earnings in the past year totalled $391.50 million.

What are Aptargroup's earnings expectations?

The current EPS estimate for Aptargroup's earnings report in Invalid Date is $1.57.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.